Avandia Approval: FDA’s Drug-Safety Protection in Doubt

Five days before a 2007 article in the New England Journal of Medicine showed that the diabetes drug Avandia was linked to a 43% increase in heart attacks compared with other medications or placebos, a group of scientists and executives from the drug’s maker, GlaxoSmithKline , gathered in a conference room at the offices of the Food and Drug Administration in White Oak, Md. The GSK goal: to convince regulators that the evidence that the company’s $3 billion-a-year blockbuster drug caused heart problems was inconclusive.

Share

NASA’s Dawn Spacecraft Is Approaching Asteroid Vesta

Schoolchildren by the thousands wept when Pluto was officially banished from the ranks of the major planets back in 2006, but for the asteroids, demotion to the interplanetary minor leagues is very old news. When Ceres was discovered in 1801 during a search of the mysteriously empty space between Mars and Jupiter, astronomers were convinced they’d found a new planet.

Share

Oil Back Above to $113 on Weaker Dollar

Oil prices climbed back to near $113 a barrel Friday as a weaker dollar made crude more attractive to investors with other currencies and the conflicts in Libya and Syria raised risk premiums. By early afternoon in Europe, benchmark crude for June delivery was up 40 cents at $113.26 a barrel in electronic trading on the New York Mercantile Exchange

Share